These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2382989)

  • 1. Lonidamine can enhance the cytotoxic effect of cisplatin in human tumour cells and rodent cells.
    Raaphorst GP; Feeley MM; Heller DP; Danjoux CE; Martin L; Maroun JA; De Sanctis AJ
    Anticancer Res; 1990; 10(4):923-7. PubMed ID: 2382989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of lonidamine alone and in combination with cisplatin on in vitro growth and viability of lung squamous cell carcinoma cell lines.
    Raaphorst GP; Ko D; Feeley MM; Danjoux CE; Maroun J; Evans WK
    Anticancer Res; 1991; 11(1):41-7. PubMed ID: 2018379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in vitro effects of lonidamine combined with cisplatin in human small cell lung cancer cell lines.
    Ko D; Raaphorst GP; Feeley MM; Danjoux CE; Maroun JA; Evans WK
    Anticancer Res; 1991; 11(1):235-9. PubMed ID: 1850216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of cisplatin cytotoxicity by lonidamine in primary cultures of human ovarian cancer.
    Orlandi L; Zaffaroni N; Gornati D; Veneroni S; Silvestrini R
    Anticancer Res; 1994; 14(3A):1161-4. PubMed ID: 8074467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxicity of lonidamine alone and in combination with other drugs against murine RIF-1 and human HT1080 cells in vitro.
    Ning SC; Hahn GM
    Cancer Res; 1990 Dec; 50(24):7867-70. PubMed ID: 2253227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphological effects of lonidamine on two human-tumor cell culture lines.
    Szekely JG; Lobreau AU; Delaney S; Raaphorst GP; Feeley M
    Scanning Microsc; 1989 Jun; 3(2):681-91; discussion 691-3. PubMed ID: 2814409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lonidamine-induced, pH dependent inhibition of cellular oxygen utilization.
    Stryker JA; Gerweck LE
    Radiat Res; 1988 Feb; 113(2):356-61. PubMed ID: 3340739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of VM-26 and lonidamine on a B16 melanoma cell line.
    Bellelli A; Bellelli L; Di Palma M; Lorenzon I; Mattioni M; Nista A; Pavese I; Rusconi V; Sezzi ML
    Anticancer Res; 1990; 10(3):565-77. PubMed ID: 2369079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of lonidamine alone or in combination with radiotherapy on survival and metabolism in human and rodent cell lines].
    Latz D; Flentje M; Eble M; Hör A; Wannenmacher M
    Strahlenther Onkol; 1991 Dec; 167(12):716-22. PubMed ID: 1763408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermal behavior of a human glioma cell line and its response to combinations of hyperthermia and lonidamine.
    Floridi A; Gentile FP; Bruno T; Delpino A; Iacobini C; Paggi MG; Castiglione S; Benassi M
    Oncol Res; 1993; 5(1):1-10. PubMed ID: 8369571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of the apoptotic response as a basis for the therapeutic synergism of lonidamine and cisplatin in combination in human tumour xenografts.
    De Cesare M; Pratesi G; Giusti A; Polizzi D; Zunino F
    Br J Cancer; 1998; 77(3):434-9. PubMed ID: 9472640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of radiation response of prostatic carcinoma by lonidamine.
    Dudak SD; Lopez A; Block NL; Lokeshwar BL
    Anticancer Res; 1996; 16(6B):3665-71. PubMed ID: 9042239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of sensitivity to hyperthermia by lonidamine in human cancer cells.
    Raaphorst GP; Feeley MM; Martin L; Danjoux CE; Maroun J; Desanctis AJ; Ko D
    Int J Hyperthermia; 1991; 7(5):763-72. PubMed ID: 1940511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth inhibition by rhein and lonidamine of human glioma cells in vitro.
    Floridi A; Gentile FP; Bruno T; Castiglione S; Zeuli M; Benassi M
    Anticancer Res; 1990; 10(6):1633-6. PubMed ID: 2285235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic synergy between pyrazoloacridine (NSC 366140) and cisplatin in vitro: inhibition of platinum-DNA adduct removal.
    Adjei AA; Budihardjo II; Rowinsky EK; Kottke TJ; Svingen PA; Buckwalter CA; Grochow LB; Donehower RC; Kaufmann SH
    Clin Cancer Res; 1997 May; 3(5):761-70. PubMed ID: 9815747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic effect of the association of BCNU with rhein or lonidamine on a human glioma cell line.
    Floridi A; Gentile PF; Bruno T; Fanciulli M; Paggi MG; Zeuli M; Benassi M
    Anticancer Res; 1991; 11(2):789-92. PubMed ID: 1648334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of tumor cell sensitivity to antineoplastic agents lonidamine and bouvardin (NSC 259968) at elevated temperatures.
    Adwankar MK; Chitnis MP
    Neoplasma; 1986; 33(2):217-23. PubMed ID: 3713924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Resistance of isolated cells from squamous cell carcinomas of the oral cavity to cytotoxic drugs].
    Eickbohm JE; Görögh T; Lippert B; Ewers R
    Dtsch Z Mund Kiefer Gesichtschir; 1991; 15(6):405-9. PubMed ID: 1726315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of lonidamine on the cytotoxicity of four alkylating agents in vitro.
    Rosbe KW; Brann TW; Holden SA; Teicher BA; Frei E
    Cancer Chemother Pharmacol; 1989; 25(1):32-6. PubMed ID: 2590999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperthermia enhanced chemosensitivity of human malignant glioma cells.
    Hermisson M; Weller M
    Anticancer Res; 2000; 20(3A):1819-23. PubMed ID: 10928113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.